Cargando…
BIOMARKER OF COVID PNEUMONIA VS CONGESTIVE HEART FAILURE: A KEY TO DISEASE DIAGNOSIS
Autores principales: | Al-janabi, Laith, Giri, Padmini, Patel, Manishkumar, Khanam, Verisha, Tusha, Jurgena, Zaki, Ahmed, Kumar, Sarwan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American College of Chest Physicians. Published by Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7548864/ http://dx.doi.org/10.1016/j.chest.2020.09.234 |
Ejemplares similares
-
SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE IN PATIENTS INFECTED WITH SARS COV-2
por: Khanam, Verisha, et al.
Publicado: (2020) -
CORTICOSTEROID TREATMENT IN PATIENTS WITH SEVERE COVID-19 PNEUMONIA
por: Hong, Gloria, et al.
Publicado: (2020) -
SUDDEN CARDIAC DEATH AND THE PECULIAR COVID-19 CASE
por: Abkouh, Danyal Taheri, et al.
Publicado: (2020) -
THE MULBSTA SCORE: PREDICTING RISK OF MORTALITY AND DISEASE SEVERITY IN PATIENTS WITH COVID-19 PNEUMONIA
por: Tusha, Jurgena, et al.
Publicado: (2020) -
THE SIGNIFICANCE OF ORAL ASCORBIC ACID IN PATIENTS WITH COVID-19
por: Patel, Manishkumar, et al.
Publicado: (2020)